# Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

> **NCT07369063** · PHASE2 · RECRUITING · sponsor: **Northwell Health** · enrollment: 30 (estimated)

## Conditions studied

- Graves Disease
- Graves' Disease
- Hyperthyroidism

## Interventions

- **DRUG:** Ergocalciferol 50,000 IU
- **DRUG:** Methimazole

## Key facts

- **NCT ID:** NCT07369063
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369063, "Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07369063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*